Brief: Journey Medical Corporation Enters Into An Exclusive License Agreement With Maruho Co., Ltd. For Qbrexza® In South Korea And Other Asian Nations
06/09/2023 16:17
Journey Medical Corp DERM.O :
* ORATION ENTERS INTO AN EXCLUSIVE LICENSE AGREEMENT WITH
MARUHO
CO., LTD. FOR QBREXZA® IN SOUTH KOREA AND OTHER ASIAN NATIONS
* UNDER TERMS OF AGREEMENT, JOURNEY MEDICAL WILL RECEIVE A
$19
MILLION NONREFUNDABLE UPFRONT PAYMENT
* JOURNEY IS STILL ELIGIBLE TO RECEIVE CERTAIN MILESTONES
PAYMENTS, TOTALING UP TO $45 MILLION
Source text for Eikon: ID:nGNX7npYmY
Further company coverage: DERM.O
Recent news on Journey Medical
See all newsJourney Medical Corp expected to post a loss of 1 cent a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Tapestry, Cisco, Sandisk
U.S. STOCKS ON THE MOVE-EnerSys, Netflix, Salesforce
U.S. STOCKS ON THE MOVE-Cerebras, Madison Square Garden Sports
U.S. STOCKS ON THE MOVE-Five Below, Salesforce, IBM, Akamai Technologies